In short, patients with LC show increased serum CYFRA21-1, SCC, and CEA, and joint test of serum tumor marker and EBUS-TBNA examination has diagnostic value for LC and can distinguish pathological types of LC. This evidence concerns the gene CEACAM5 and laryngotracheoesophageal cleft.